TRANSVAC2 offers technical services at all stages of the Vaccine R&D pipeline to support the development of prophylactic and therapeutic vaccines for human and veterinary use.

Apply until August 5th

Open Call:

TRANSVAC: New Vaccines Faster

TRANSVAC is a collaborative infrastructure project funded by the European Commission (EC), initially under the 7th Framework Programme (FP7) and currently under Horizon 2020.  The project is a joint effort of leading European groups working in the field of vaccine development, and is coordinated by the European Vaccine Initiative (EVI). TRANSVAC is designed to accelerate vaccine development by enhancing European vaccine research and training, and increase sustainability of EC vaccine projects by implementing a permanent research infrastructure for early vaccine development.


Submit your application for Vaccine Development Services and Training

Services at all stages

of the Vaccine R&D Pipeline

Free technical & theoretical courses at leading European centres

Support to development of vaccines against COVID19

Researchers developing vaccine candidates against #COVID19 are encouraged to apply and benefit

from all TRANSVAC2 services, such as:

  Adjuvant formulation - Statens Serum Institut and Helmholtz Centre for Infection Research
   Structural Biology - INSTRUCT

  Systems Biology - Bioaster, UNISI, Leiden University

   Animal modelsCEABPRC and Helmholtz Centre for Infection Research 
   Clinical Trial Support - ECRIN 

 Check out all services available here 


For specific inquiries on the details of each service available please contact directly service providers

SARS-CoV-2 illustration:Centers for Disease Control and Prevention (CDC)  Image by: CDC/ Alissa Eckert, MS; Dan Higgins, MAMS




along the value chain

Communication & Collaboration

Discovery & Pre-clinical

Data Management

and E-Infrastructure

Clinical Development




This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement N° 730964.

Be the first to know about the upcoming application calls, follow European Vaccine Initiative on:

  • LinkedIn Social Icon
  • Twitter Social Icon
Subscribe to TRANSVAC´s Mailing list

© 2020 European Vaccine Initiative. Designed by European Vaccine Initiative